An Innovative Technique of Transurethral Seminal Vesiculoscopy with Ultrasonic Lithotripter for Severe Persistent Hematospermia
Tong Zhou,Guanghua Chen,Wei Zhang,Shengfei Qin,Guangan Xiao,Lei Wang,Yinghao Sun
DOI: https://doi.org/10.1089/vid.2018.0015
2018-01-01
Videourology
Abstract:Introduction: To introduce an innovative technique of transurethral seminal vesiculoscopy (TSV) with ultrasonic lithotripter for severe persistent hematospermia. Materials and Methods: From May 2012 to December 2015, totally 14 patients with severe persistent hematospermia underwent TSV with an ultrasonic lithotripter. For the patient with a positive urine solution microorganism culture, the sensitive antimicrobial therapy is administrated and the negative culture outcome is confirmed before the TSV procedure.1,2 Under general anesthesia, the patient is positioned in the standard lithotomy position. The 8F rigid ureteroscopy used as the seminal vesiculoscopy is inserted retrogradely, under the guidance of a 0.032-inch Zebra guidewire, through the utricular orifice at the verumontanum.3 After entering the lumen, the Zebra guidewire is further introduced through the ejaculatory duct orifice to guide the ureteroscopy entering seminal vesicle. If the orifice is masked behind a thin transparent membrane-like wall, tentative penetration with the soft head of guidewire is performed to identify the orifice. The whole seminal vesicle is first inspected to exclude malignant lesions. Then a 3.3F ultrasonic lithotripter with 40% energy is introduced through the working channel of seminal vesiculoscopy. The ultrasonic lithotripter can easily remove stone fragments even for large calculi, and get rid of the blood clot or purulence in the seminal vesicle. Its strong and continuous suction function provides a clear surgical field and simultaneously keeps the pressure of seminal vesicle as low as possible. Finally, the 0.5% levofloxacin solution is injected, and a urethral Foley catheter is placed overnight. Additional oral quinolone antibiotic is given during hospitalization. All the patients are informed not to have sexual intercourse for at least four weeks.4 Results: The average age of included patients was 44 (range: 24–66) years. The average disease duration was 38 ±40 (range: 6–120) months, and the median follow-up time was 31 (range: 19–36) months. In almost all the patients, blood clots were observed accompanying with mucosal edema, congestion, and bleeding. Particulate calculi were detected in the verumontanum lumen or seminal vesicle in nine patients (64.3%). Moreover, the yellow-brown calculi were found to obstruct the ejaculatory duct in three patients (21.4%). All the TSV procedures were effective but one patient had a two-stage procedure because of the seminal vesicle stones accompanying with pus. The mean operative time was 50 (range: 20–93) minutes, and the mean postoperative hospitalization was 2 days. Accompanying symptoms such as discomfort or pain in perineal region, frequent micturition, and ejaculatory pain/discomfort were, respectively, alleviated in three of four, two of three, and three of three patients. Transrectal ultrasonograhy or computed tomography confirmed resolution of seminal vesicle blood clot, absence of seminal vesicle calculi, reduction of seminal vesicle volume, and disappearance of seminal vesiculitis, respectively, in 5 of 5, 4 of 5, 8 of 10, and 6 of 7 patients. During the follow-up, all the patients did not have recurrence of hematospermia. Furthermore, no postoperative epididymitis, retrograde ejaculation, rectal injury, incontinence, bladder neck contracture, or erectile dysfunction happened. Conclusions: Our initial experience demonstrates that TSV with ultrasonic lithotripter enables a more reliable, effective, and convenient procedure to diagnose and treat severe persistent hematospermia than the traditional technique. The innovative technique greatly controls the recurrent hematospermia with less operative time and fewer complications.5 No competing financial interests exist. Runtime of video: 3 mins 14 secs